Mason Capital Management LLC, a global event driven hedge fund, has announced a tender offer for all outstanding ADSs and Ordinary Shares in Forward Pharma A/S at a competitive purchase price. The Tender Offer is set to expire on June 12, 2024, providing holders of ADSs and Ordinary Shares with an opportunity to participate.
Mason Capital, with assets under management of $1.37 billion, aims to generate consistent positive returns in any market environment. The Tender Offer is being conducted in accordance with the terms outlined in the Offer to Purchase and related materials. Holders of ADSs and Ordinary Shares are encouraged to review the details of the Tender Offer before making a decision.
Holders who wish to participate in the Tender Offer can obtain the necessary materials by contacting MacKenzie Partners at 800-322-2885. Once all conditions are met, Mason Capital will purchase the tendered ADSs and Ordinary Shares promptly following the Expiration Date. Any securities tendered into the offer cannot be withdrawn, providing certainty for participants.
Mason Capital does not provide recommendations on whether holders should tender their securities, leaving the decision to the individual holder. The Tender Offer is being conducted in compliance with applicable securities laws and regulations, ensuring a transparent and lawful process for all participants.
For more information about the Tender Offer and Mason Capital, interested parties can refer to the detailed Tender Offer Materials. With a focus on absolute returns, Mason Capital strives to deliver value to its investors through strategic investment decisions.
This press release serves as a formal announcement of the Tender Offer and does not constitute a solicitation of new securities or an offer to purchase securities. Capitalized terms used in this release are defined in the Tender Offer Materials for clarity and consistency in communication.
Investors looking to participate in the Tender Offer should act promptly and review the materials provided to make an informed decision. Mason Capital remains committed to providing value to its investors and executing strategic investment opportunities for continued growth and success.
Source link
